Lupin's US based subsidiary, Lupin Pharmaceuticals Inc has received final approval from US FDA for levonoregestrel tablets USP, 0.75 mg (Rx/OTC) to market a generic version of Teva Branded Pharmaceutical Products R&D, Inc's Plan Be tablets, 0.75.mg.
Levonorgestrel tablet is a progestin-only emergency contraceptive, indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure.
Plan B tablets had annual US sales of approximately US$ 81.1 million.